Reason for request
Re-assessment of Actual Benefit in compliance with article R. 163-21 of the French Social Security Code.
Clinical Benefit
| Insufficient |
The Committee considers that the actual benefit of AVANDIA and AVANDAMET products is now insufficient for it to be paid for by National Health Insurance, in comparison with existing therapies. |
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
A1ZX3UP1hms2CF25
